CRISPR Therapeutics $200 million public offering

24/9/2018
Share offer

$ 200 million

Completed

24/9/2018


Overview:

  • Biopharmaceuitcal company CRISPR Therapeutics has closed a publicly offering of its 4,210,526 shares for $200 million.

Rajeeb gurung - Researcher

Jurisdiction:

Switzerland

Deal type:

Share offer

Practice area:

Capital markets : Equity

Industry sector:

Pharmaceuticals and life sciences


Firms:

Party: CRISPR Therapeutics (Issuer)


Party: CRISPR Therapeutics (Issuer)